** = Publications listed in SCI/SSCI/Pubmed
** Robinson, I; Bertsch, A; Leithner, K; Stiegler, P; Olschewski, H; Hrzenjak, A
Circulating microRNAs as molecular biomarkers for lung adenocarcinoma.
Cancer Biomark. 2022; 34(4):591-606
Doi: 10.3233/CBM-210205
Web of Science
PubMed
FullText
FullText_MUG
** Seidl, C; Panzitt, K; Bertsch, A; Brcic, L; Schein, S; Mack, M; Leithner, K; Prinz, F; Olschewski, H; Kornmueller, K; Hrzenjak, A
MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Cancer Lett. 2020; 469: 266-276.
Doi: 10.1016/j.canlet.2019.10.044
Web of Science
PubMed
FullText
FullText_MUG
** Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A
Histone deacetylase inhibitor panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma via HIF-1α destabilisation
Wiener Klinische Wochenschrift. 2015; 127: 816-817.-Annual Meeting of the Austrian Society of Pneumology; Oct 15-17, 2015; Graz, Austria.
[Poster]
Web of Science